Search


	Podcast:		JAMA Clinical Reviews
	Episode:		Dual Antiplatelet Therapy After Acute Coronary Syndrome
	Category:		Health
	Duration:		00:24:10
	Publish Date:		2021-04-20 15:00:00
	Description:		Dual antiplatelet therapy, typically aspirin and an oral P2Y12 receptor inhibitor (clopidogrel, prasugrel, ticagrelor, cangrelor), reduces adverse events after acute coronary syndrome (ACS) but choice of agent and optimal duration may be patient-specific. Umair Khalid, MD, a cardiologist at the Baylor School of Medicine in Houston, discusses how to use these agents in management of ACS. Related Article(s): Oral Antiplatelet Therapy After Acute Coronary Syndrome
	Total Play:		0

Some more Podcasts by American Medical Association

1K+ Episodes

JAMA Editors .. 1